{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:46Z","timestamp":1777354666445,"version":"3.51.4"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The post-covid-syndrome (PCS) is characterized by severe persisting fatigue and other long haul symptoms following COVID-19 infection. Disease-driving mechanisms are elusive, biomarkers are missing, treatment options few, and yet millions of people worldwide are affected. We hypothesized that the common complaint of polydipsia\/polyuria and its attendant effect on osmolality can be quantified and identified as an unrecognized clinical feature of the PCS. We conducted a clinical case-series of 10 consecutive patients with PCS (5 females, 5 males; mean age 44 \u00b1 14 y) who completed questionnaires covering health status, quality-of-life and post-covid symptoms. Detailed anamnestic work-up and clinical assessment were performed, and serum and urine osmolality (S-osm, U-osm) were determined after overnight fasting and fluid deprivation. Polydipsia and\/or polyuria were reported by 7 patients, and measures of osmolality were abnormal in all 10 individuals. S-osm was above the reference range (285\u2013292 mOsm\/kg) in 9\/10 patients (mean 298 \u00b1 4), and U-osm was below the reference (&amp;gt;750 mOsm\/kg) in 7\/10 patients (mean 707 \u00b1 149). The combination of high serum and low urine osmolality (n=6) was associated with poorer health status, when compared to single abnormality only (n=4). Signs of connective tissue disorders were common among participants, as were previous head-and-neck traumas and activities associated with myofascial distension. Data from this uncontrolled limited sized case series suggests disrupted fluid homeostasis as an unrecognized clinical feature of the PCS. The objective findings of high serum and low urine osmolality are candidates for diagnostic biomarkers as well as potential therapeutic targets and outcome measures.<\/jats:p>","DOI":"10.3389\/fendo.2026.1741517","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:36:35Z","timestamp":1777350995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Disrupted fluid homeostasis in patients with post-Covid-19 syndrome \u2013 a case series"],"prefix":"10.3389","volume":"17","author":[{"given":"Helena","family":"Huhmar","sequence":"first","affiliation":[{"name":"Brag\u00e9e Clinics","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo C.","family":"Bertilson","sequence":"additional","affiliation":[{"name":"Brag\u00e9e Clinics","place":["Stockholm, Sweden"]},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet","place":["Huddinge, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olli","family":"Polo","sequence":"additional","affiliation":[{"name":"Brag\u00e9e Clinics","place":["Stockholm, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Brag\u00e9e","sequence":"additional","affiliation":[{"name":"Brag\u00e9e Clinics","place":["Stockholm, Sweden"]},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet","place":["Huddinge, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Sj\u00f6gren","sequence":"additional","affiliation":[{"name":"Brag\u00e9e Clinics","place":["Stockholm, Sweden"]},{"name":"Department of Neurobiology, Care Sciences and Society, Karolinska Institutet","place":["Huddinge, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3026","article-title":"Management of post-acute covid-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"Bmj"},{"key":"B2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/jpm13020334","article-title":"Long COVID: clinical framing, biomarkers, and therapeutic approaches","volume":"13","author":"Conti","year":"2023","journal-title":"J Pers Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1187163","DOI":"10.3389\/fmed.2023.1187163","article-title":"ME\/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature","volume":"10","author":"Komaroff","year":"2023","journal-title":"Front Med (Laus)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S1530-891X(25)01349-7","DOI":"10.1016\/j.eprac.2025.12.020","article-title":"Low vasopressin in myalgic encephalomyelitise\/chronic fatigue syndrome","volume":"29","author":"Huhmar","year":"2025","journal-title":"Endocr Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2021.11.013","article-title":"Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"40","author":"Sukocheva","year":"2022","journal-title":"J Adv Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1042\/cs20090055","article-title":"Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function","volume":"118","author":"Hurwitz","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.06.045","article-title":"Chronic fatigue syndrome and cardiovascular disease: JACC state-of-the-art review","volume":"78","author":"Natelson","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"A2576","DOI":"10.1016\/j.chest.2020.09.172","article-title":"Diabetes insipidus as a symptom of covid-19 infection: case report","volume":"158","author":"Rajevac","year":"2020","journal-title":"Chest"},{"key":"B11","article-title":"Central diabetes insipidus as potential endocrine manifestation of COVID 19 infection","volume":"8","author":"Kambiz","year":"2023","journal-title":"World J Pharm Life Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01627-z","article-title":"Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection","volume":"44","author":"Misgar","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B13","first-page":"222","article-title":"Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report","volume":"38","author":"Sheikh","year":"2021","journal-title":"Pan Afr Med J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2324709621999954","DOI":"10.1177\/2324709621999954","article-title":"Diabetes insipidus and concomitant myocarditis: A late sequelae of COVID-19 infection","volume":"9","author":"Sheikh","year":"2021","journal-title":"J Investig Med High Imp Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12902-022-01048-w","article-title":"Central diabetes insipidus secondary to COVID-19 infection: a case report","volume":"22","author":"Yavari","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43884","article-title":"Central diabetes insipidus: an acute manifestation of COVID-19 infection","volume":"15","author":"Suresh Kumar","year":"2023","journal-title":"Cureus"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27878","article-title":"The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome","volume":"94","author":"Sivan","year":"2022","journal-title":"J Med Virol"},{"key":"B18","first-page":"1168","volume-title":"Guyton and Hall textbook of medical physiology","author":"Hall","year":"2016"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1993.tb04108.x","article-title":"Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome","volume":"87","author":"Bakheit","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1601599","DOI":"10.3389\/fneur.2025.1601599","article-title":"Beneficial effects of intermittent intravenous saline infusion in dysautonomic patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: a case-series","volume":"16","author":"Sj\u00f6gren","year":"2025","journal-title":"Front Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11154-020-09569-2","article-title":"Endocrine and metabolic aspects of the COVID-19 pandemic","volume":"21","author":"Marazuela","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26943","article-title":"What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2","volume":"93","author":"Li","year":"2021","journal-title":"J Med Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fneur.2020.00828","article-title":"Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"11","author":"Brag\u00e9e","year":"2020","journal-title":"Front Neurol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1741517\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:36:39Z","timestamp":1777350999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1741517\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":23,"alternative-id":["10.3389\/fendo.2026.1741517"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1741517","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1741517"}}